Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | IL-1 alpha | 100 | ng/mL | 2 | MMP-3 | 5101.5 | 52 | ||||
N2645 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | MMP-3 | 1251.5 | 54 | |
N2645 | IL-1 alpha | 100 | ng/mL | 2 | MMP-3 | 1630.0 | 53 | ||||
RA2708 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | MMP-3 | 31725.0 | 34 | |
RA2708 | IL-1 alpha | 100 | ng/mL | 2 | MMP-3 | 33556.0 | 44 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | MMP-3 | 87.0 | 57 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | MMP-3 | 113.0 | 33 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | MMP-3 | 38.5 | 48 | |
N2645 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | MMP-3 | 40.0 | 37 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | MMP-3 | 546.0 | 54 | |
RA2708 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | MMP-3 | 905.0 | 41 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | MMP-3 | 176.5 | 46 | |
RA2159 | Poly(I:C) | 2 | ug/mL | 2 | MMP-3 | 469.0 | 29 | ||||
N2645 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | MMP-3 | 54.5 | 46 | |
N2645 | Poly(I:C) | 2 | ug/mL | 2 | MMP-3 | 64.0 | 36 | ||||
RA2708 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | MMP-3 | 2625.0 | 47 | |
RA2708 | Poly(I:C) | 2 | ug/mL | 2 | MMP-3 | 2551.0 | 36 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | 2 | MMP-3 | 78.0 | 48 | ||||
RA2159 | IKK16 | 2.0 | uM | 2 | MMP-3 | 101.0 | 49 | ||||
N2645 | 5z-7-oxozeaenol | 0.6 | uM | 2 | MMP-3 | 36.0 | 48 | ||||
N2645 | IKK16 | 2.0 | uM | 2 | MMP-3 | 43.0 | 53 | ||||
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | 2 | MMP-3 | 2458.0 | 54 | ||||
RA2708 | IKK16 | 2.0 | uM | 2 | MMP-3 | 639.0 | 63 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 2 | MMP-3 | 114.0 | 48 | ||||
RA2159 | 2 | MMP-3 | 101.0 | 51 |